Template:Valganciclovir hydrochloride: Difference between revisions

Latest revision as of 14:30, 30 December 2013

Valganciclovir Hydrochloride
VALCYTE^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
Patient Counseling Information
How Supplied
Labels and Packages

@@ Line 1: / Line 1: @@
 {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
-! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[valganciclovir hydrochloride|{{fontcolor|#6C7B8B|valganciclovir hydrochloride}}]]'''''
+! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[valganciclovir hydrochloride|{{fontcolor|#6C7B8B|Valganciclovir Hydrochloride}}]]'''''
 |-
 ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | VALCYTE<sup>®</sup> FDA Package Insert
@@ Line 24: / Line 24: @@
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[valganciclovir hydrochloride dosage and administration|Dosage and Administration]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[valganciclovir hydrochloride patient counseling information|Patient Counseling Information]]
 |-